Dianthus Therapeutics (DNTH) Research & Development (2017 - 2025)
Historic Research & Development for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $32.5 million.
- Dianthus Therapeutics' Research & Development rose 2718.84% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.2 million, marking a year-over-year increase of 7130.11%. This contributed to the annual value of $83.1 million for FY2024, which is 15305.26% up from last year.
- Per Dianthus Therapeutics' latest filing, its Research & Development stood at $32.5 million for Q3 2025, which was up 2718.84% from $26.3 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Research & Development registered a high of $32.5 million during Q3 2025, and its lowest value of $5.8 million during Q1 2023.
- For the 4-year period, Dianthus Therapeutics' Research & Development averaged around $16.8 million, with its median value being $13.1 million (2024).
- Its Research & Development has fluctuated over the past 5 years, first tumbled by 1068.05% in 2023, then skyrocketed by 22090.45% in 2024.
- Dianthus Therapeutics' Research & Development (Quarter) stood at $9.8 million in 2022, then decreased by 10.68% to $8.8 million in 2023, then soared by 200.8% to $26.4 million in 2024, then grew by 23.0% to $32.5 million in 2025.
- Its Research & Development was $32.5 million in Q3 2025, compared to $26.3 million in Q2 2025 and $27.0 million in Q1 2025.